Original Research
Published on 12 May 2025
Esmolol improves sepsis outcomes through cardiovascular and immune modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1498227
- 434 views
Type at least 3 characters
1,746 articles
Original Research
Accepted on 09 May 2025
URINARY URODILATIN LEVELS IN PATIENTS WITH RENAL SALT WASTING SYNDROME AS A POSSIBLE NEW DIAGNOSTIC MARKER. A PILOT STUDY
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1579699
- 129 views
Original Research
Published on 09 May 2025
Suppressing chondrocyte cuproptosis by syringaresinol-4-O-β-d-glucoside alleviates gouty arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565422
- 634 views
Review
Published on 09 May 2025
Natural saponins and macrophage polarization: Mechanistic insights and therapeutic perspectives in disease management
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1584035
- 621 views
Original Research
Published on 08 May 2025
Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1590096
- 1,038 views
Review
Published on 06 May 2025
Curcumin: a potential anti-photoaging agent
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559032
- 950 views
Review
Accepted on 05 May 2025
Targeting the cGAS-STING Pathway: Emerging Strategies and Challenges for the Treatment of Inflammatory Skin Diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597443
Original Research
Published on 30 Apr 2025
Effect of methotrexate/dexamethasone combination on epithelial-mesenchymal transition and inflammation gene expression of human RPE cells in-vitro
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569703
- 610 views
Original Research
Published on 29 Apr 2025
Irisin restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis via regulating microglia activation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561939
- 613 views
Original Research
Published on 28 Apr 2025
Anti-inflammatory effect and mechanism of stytontriterpene D on RAW264.7 cells and zebrafish
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559022
- 1,129 views
Original Research
Accepted on 25 Apr 2025
Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572604
- 256 views
Original Research
Published on 25 Apr 2025
The immunostimulatory activity of Epimedium flavonoids involves toll-like receptor 7/8
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1514284
- 672 views
Original Research
Published on 25 Apr 2025
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565909
- 1,042 views
- 1 citation
Editorial
Published on 25 Apr 2025
Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1602495
- 1,074 views
Original Research
Published on 24 Apr 2025
S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1590816
- 1,163 views
Original Research
Published on 23 Apr 2025
Tetramethylpyrazine alleviates acute pancreatitis inflammation by inhibiting pyroptosis via the NRF2 pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1557681
- 818 views